SSII · SS Innovations International, Inc.
$3.60
-0.11 (-2.96%)
At close · Aug 19
Going-concern doubt
— flagged Aug 13, 2026
Substantial doubt about the company's ability to continue as a going concern.
“These conditions raise substantial doubt about the Company's ability to continue as a going concern within one year after the date that the unaudited interim condensed consolidated financial statements are issued.”View the 10-Q filed Aug 13, 2026
Market Cap
$745.95M
Shares
200.39M
Price & Indicators
20d MA
50d MA
200d MA
Earnings
Filing
Insider
Congress
Investor day
Close$3.60
Open$3.74
Day$3.57–3.81
52W close$3.29–9.98
Avg vol 30d65K
Short int79K · 0.0% float · 1.0d
Short vol17%
Last earningsOct 28, 2025
DataAug 2024–Aug 2026
Filing10-Q · Aug 13
Up next
FQ3-26 quarter ends
~Sep 30, 2026
Est
filed Aug 13, 2026
Equibles Rating
blended score · not investment adviceOverall
Sell
SellHoldBuy
Technical
Sell
Momentum
Very Weak
Sentiment
Neutral
Fundamentals
Excellent
Quant / Vol
Very High
Market backdrop
VIX 14.9 · calm
Equity put/call 0.52
Technical
price trend
50 / 200-day cross
No cross
Price vs 200-day avg
−23%
below
Price vs 50-day avg
−2%
below
RSI (14)
44
neutral
MACD trend
Negative
52-week position
5%
near low
Momentum
relative strength
1-month return
+1%
trailing
6-month return
−24%
trailing
YTD return
−37%
this year
Relative strength
−36%
vs S&P · 6-mo
Sentiment
smart money
Trend (MA cross)
No cross
50d $4 › 200d $5 — 200d above 50d
Institutional flow
Distributing
-12% holders QoQ · +1 funds added
Insider flow
Flat
No net insider activity over 90 days
Short interest
Falling
0.04% of float · ▼ -39.7% MoM · 1.0 days cover
Volume signal
Normal
Volume near normal
Institution breadth
Steady
23 holders — mid 1-yr range
Squeeze score
29
low risk · 0–100
Fundamentals
Revenue growth
+106%
Y/Y
Gross margin
46%
expanding
EPS growth
+45%
Y/Y
Free cash flow
$-22.2M
Balance sheet
$2.2M
net cash
Quant / Vol
risk profile
Volatility
95%
annualized · 1-yr
Max drawdown
−67%
past year
ATR
6.9%
of price · 14-day
Blended from price, momentum, positioning, fundamentals & volatility · daily-close · not investment advice. Market backdrop is context, not part of the score.
Technicals
trend & momentum for long-term holders Sell
50 / 200-day cross
No cross
Neutral
Price vs 200-day avg
−23%
Bearish
Price vs 50-day avg
−2%
Neutral
RSI (14)
44
Neutral
MACD trend
Negative
Bearish
52-week position
5%
Bearish
Market signals — smart money & positioning
Mixed
Trend (MA cross)
No cross
50d $4 › 200d $5 — 200d above 50d
Institutional flow
Distributing
-12% holders QoQ · +1 funds added
Insider flow
Flat
No net insider activity over 90 days
Short interest
Falling
0.04% of float · ▼ -39.7% MoM · 1.0 days cover
Volume signal
Normal
Volume near normal
Institution breadth
Steady
23 holders — mid 1-yr range
Price context
position in its 52-week range
Range low $3
Now $4 · 5%
Range high $10
vs 200-day avg -23%
vs 50-day avg -2%
Illustrative technical + ownership context — a signal mix, not investment advice.
Key metrics
the company's own KPIs, from written earnings releases and filings| Metric | Latest | Period | YoY |
|---|---|---|---|
| Cumulative surgeries | 12,272 | As of June 30, 2026 | — |
| SSi Mantra cumulative installed base | 224 | As of June 30, 2026 | — |
| SSi Mantra installations | 56 | H1 2026 | — |
|
|
|||
| SSi Mantra surgeries | 4,387 | H1 2026 | — |
|
|
|||
| SSi Mantra surgical robotic system installations | 56 | H1 2026 | — |
|
|
|||
Figures exactly as the company stated them in writing · click a metric with a to chart its history · period links open the stating document · "filing" marks figures stated in the 10-K/10-Q · YoY needs an exactly comparable prior-year period
Versus peers
Medical Devices — same industry group| Company | Mkt cap | YTD | Rev growth Y/Y | P/E | Short % shares |
|---|---|---|---|---|---|
|
SSII
this stock
SS Innovations International, Inc.
|
$745.95M | -36.6% | +105.7% | — | 0.0% |
|
ABT
Abbott Laboratories
|
$196.27B | -8.7% | +5.7% | 31.6 | 1.3% |
|
SYK
Stryker Corp
|
$127.34B | -3.3% | +11.2% | 34.4 | 2.2% |
|
MDT
Medtronic plc
|
$115.97B | -2.0% | +8.4% | 24.3 | 1.4% |
|
BSX
Boston Scientific Corp
|
$73.14B | -45.5% | +12.5% | 20.4 | 1.5% |
Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding
At a glance
key data from every sectionOwnership
Short & Settlement
Financials
Filings
Earnings & Events
Performance
| 5D | 20D | 120D | MTD | YTD | |
|---|---|---|---|---|---|
| SSII | -2.4% | +0.6% | -24.2% | -9.6% | -36.6% |
| SPY | -0.4% | +2.9% | +11.6% | +3.0% | +12.8% |
| vs SPY | -2.0% | -2.3% | -35.8% | -12.5% | -49.4% |